Aura Biosciences Inc.

AURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.36

-$0.08 (-1.24%)

At close: Sep 21, 2026, 4:00 PM ET

$6.24

-$0.12 (-1.89%)

After-hours: Sep 21, 2026, 7:55 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.24%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $657.86M

1D Range

6.25 6.46

52W Range

4.73 9.54

Valuation (TTM)

PE -3.57

PB 2.09

EV/EBITDA -2.66

Valuation (NTM)

Forward PE N/A

Forward PEG 0.41

Price Target $17.50

Cash Flow

FCF Yield -15.6%

SBC Adj. FCF Yield -19.1%

SBC Impact -22.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 0.3% | 2.5%

FCF 3Y | 5Y -16.2% | -17.8%

Returns

ROA -37.6%

ROE -73.2%

ROIC -41.6%

Financial Health

Net Cash

$323.84M

Current Ratio 16.82

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary vi...

Sector Healthcare

Industry Biotechnology

Employees 113

IPO Date Oct 28, 2021

Website www.aurabiosciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$17.50

Upside

+175.16%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞